Evidence map›Paper›PMID 20225900›Full record

ReviewChemical reviews2010

Multimodality imaging probes: design and challenges.

Angelique Louie

Abstract readReview
In one paragraph

Review in Chemical reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 234 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
234citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

234 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Tetrazine-Inorganic chemistry frontiers · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. ROS-Responsive Fluorinated Oxalate Nanomedicine for Dual Chemiluminescence/International journal of molecular sciences · 2025
    Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

174 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Angelique LouieDepartment of Biomedical Engineering, University of California, Davis, California 95616, USA. aylouie@ucdavis.edu

Funding

Multimodal mPET &mMRI Imaging InstrumentationR01EB000993 · NIBIB · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI CHERRY, SIMON R, JACOBS, RUSSELL E · 2004 to 2013
$9.2M
Nontoxic Si Nanoprobes for Mulitple Biomarker ImagingR01EB008576 · NIBIB · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LOUIE, ANGELIQUE Y · 2008 to 2011
$1.3M
Macrophage specific magnetic-fluorescent nanoprobesR21HL081108 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI LOUIE, ANGELIQUE Y · 2005 to 2006
$402k
NHLBI NIH HHS R21 HL081108NIBIB NIH HHS R01 EB000993NIBIB NIH HHS R01 EB008576
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug DesignMolecular ProbesAnimalsDiagnostic ImagingGenetic EngineeringHumansLipidsNanoparticlesLipidsMolecular Probes

Identifiers

PMID20225900
PMCPMC2878382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.